Changing the FACE of Dermatology and Ophthalmology
Attillaps is a developmental stage pharmaceutical company, pioneering a novel drug platform for the treatment of inflammatory conditions in ophthalmology and dermatology.
Attillaps leverages its target discovery and characterization expertise to identify new pathways and develop unique, first-in-class therapies by repositioning compounds to treat cutaneous inflammatory conditions.